WHO ICTRP trial
Adjuvant treatment of Graves´ ophthalmopathy with NSAID (aGO study) - aGO study
EUCTR2005-000832-26-SE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2005-000832-26-SE |
|---|---|
| Public title | Adjuvant treatment of Graves´ ophthalmopathy with NSAID (aGO study) - aGO study |
| Scientific title | Adjuvant treatment of Graves´ ophthalmopathy with NSAID (aGO study) - aGO study |
| Primary sponsor | Department of Endocrinology |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Graves´ophthalmopathy |
| Interventions | Trade Name: Diclofenac T ratiopharm Product Name: Diclofenac T ratiopharm Pharmaceutical Form: Tablet Concentration unit: mg milligram(s) |
| Registration date | Nov 3, 2005 |
| Target size | 300 |
| Secondary IDs | 2005 02 03 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: